Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?
- PMID: 16905692
- PMCID: PMC1860037
- DOI: 10.1136/gut.2005.083121
Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?
Abstract
Although the precise causes of inflammatory bowel disease (IBD) have yet to be discovered, important therapeutic advances have resulted from the manipulation of cytokine function(s) using anticytokine/cytokine therapies, such as targeting of tumor necrosis factor. We discuss the future of this area of investigation in the context of preclinical experimentation using animal models of IBD. In particular, we pinpoint the roles played by interleukin 6 and its intracellular signalling pathways in the SAMP1/Yit murine model of Crohn's-like ileitis.
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.Gut. 2006 Sep;55(9):1263-9. doi: 10.1136/gut.2005.079343. Epub 2006 May 8. Gut. 2006. PMID: 16682432 Free PMC article.
References
-
- Pizarro T T, Arseneau K O, Bamiaset al Mouse models for the study of Crohn's disease. Trends Mol Med 20039218–222. - PubMed
-
- Strober W, Fuss I J, Blumberg R S. The immunology of mucosal models of inflammation. Annu Rev Immunol 200220495–549. - PubMed
-
- Bahn A K, Mizoguchi E, Smith R N.et al Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999169195–207. - PubMed
-
- Kuhn R, Lohler J, Rennick D.et al Interleukin‐10‐deficient mice develop chronic enterocolitis. Cell 199375263–274. - PubMed
-
- Steidler L, Hans W, Schotte L.et al Treatment of murine colitis by Lactococcus lactis secreting interleukin‐10. Science 20002891352–1355. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical